clonidine has been researched along with metoclopramide in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (26.67) | 18.7374 |
1990's | 7 (23.33) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 4 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Groszmann, RJ; Rodríguez-Pérez, F | 1 |
Chee, KY; Sachdev, P | 1 |
Ikeda, M; Koshida, H; Matsubara, T; Miyamori, I; Okamoto, S; Soma, R; Takeda, R | 1 |
Hashimoto, H; Hasui, M; Igarashi, N; Kato, E; Minami, S; Okabe, T; Sato, T | 1 |
Cooper, SM; McRitchie, B | 1 |
Baranowska, B; Jeske, W; Nowakowski, J; Singh, SP; Soszynski, P | 1 |
Christensen, NJ; Eldrup, E; Hagen, C; Olgaard, K | 1 |
Borsini, F; Nowakowska, E; Samanin, R | 1 |
Spedding, M | 1 |
Hurtado, E; Lanes, R | 1 |
Fenton, HM; Liebman, JM | 1 |
Schirger, A; Schwartz, GL | 1 |
LaPointe, J; Slavik, KJ | 1 |
Amorosi, A; Credi, G; Ianni, L; Lanzillotti, R; Mannelli, M; Pratesi, C; Pupilli, C | 1 |
Hall, JE; Martin, KA; Perkins, RB | 1 |
Castagné, V; Goineau, S; Guillaume, P | 1 |
2 review(s) available for clonidine and metoclopramide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Clonidine; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Metoclopramide; Molsidomine; Nitrates; Nitroglycerin; Serotonin Antagonists; Somatostatin; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1992 |
2 trial(s) available for clonidine and metoclopramide
Article | Year |
---|---|
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Amenorrhea; Clonidine; Dopamine Antagonists; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Longitudinal Studies; Luteinizing Hormone; Metoclopramide; Naloxone; Narcotic Antagonists; Neurosecretory Systems; Neurotransmitter Agents; Sleep | 1999 |
26 other study(ies) available for clonidine and metoclopramide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Pressure; Clonidine; Epinephrine; Female; Glucagon; Humans; Kinetics; Male; Metoclopramide; Middle Aged; Naloxone; Norepinephrine; Pheochromocytoma | 1990 |
Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge.
Topics: Adolescent; Adrenocorticotropic Hormone; Arginine Vasopressin; Child, Preschool; Clonidine; Dinoprostone; Dopamine; Epinephrine; Female; Humans; Hypertension; Indomethacin; Levodopa; Metoclopramide; Norepinephrine; Periodicity; Prostaglandins E; Psychotic Disorders; Recurrence; Syndrome; Vomiting | 1988 |
Role of dopamine and alpha-adrenoreceptors in the control of gastric emptying in the rat: possible involvement in the mechanism of action of metoclopramide.
Topics: Adrenergic alpha-Antagonists; Animals; Clonidine; Gastric Emptying; Male; Metoclopramide; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes | 1985 |
The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; beta-Endorphin; Clonidine; Female; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Metoclopramide; Naloxone; Obesity; Prolactin; Receptors, Dopamine; Receptors, Opioid | 1987 |
Plasma free and sulfoconjugated dopamine in man: relationship to sympathetic activity, adrenal function and meals.
Topics: Adrenal Glands; Adult; Clonidine; Dopamine; Food; Humans; Male; Metoclopramide; Middle Aged; Receptors, Dopamine; Sulfates; Sympathetic Nervous System | 1988 |
Effect of repeated treatment with desipramine in the behavioral "despair" test in rats: antagonism by "atypical" but not "classical" neuroleptics or antiadrenergic drugs.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Clonidine; Clozapine; Depressive Disorder; Desipramine; Dibenzazepines; Haloperidol; Humans; Male; Metoclopramide; Phentolamine; Prazosin; Propranolol; Rats; Sulpiride | 1984 |
Effects of metoclopramide and isoprenaline in the rat vas deferens; interactions with alpha-adrenoceptors.
Topics: Animals; Benzamides; Clonidine; Electric Stimulation; In Vitro Techniques; Isoproterenol; Male; Metoclopramide; Muscle Contraction; Muscle, Smooth; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Vas Deferens | 1980 |
Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects.
Topics: Administration, Oral; Adolescent; Blood Glucose; Child; Clonidine; Female; Growth Hormone; Humans; Hydrocortisone; Insulin; Male; Metoclopramide; Puberty | 1982 |
Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit.
Topics: Animals; Baclofen; Clonidine; Conditioning, Operant; Dopamine Antagonists; Extinction, Psychological; Haloperidol; Male; Methocarbamol; Metoclopramide; Prazosin; Rats; Rats, Inbred F344; Receptors, Dopamine; Self Stimulation | 1982 |
Orthostatic hypotension.
Topics: Cerebrovascular Circulation; Clonidine; Deamino Arginine Vasopressin; Dihydroergotamine; Dopamine; Epinephrine; Humans; Hypotension, Orthostatic; Metoclopramide; Octreotide; Patient Education as Topic; Pindolol; Yohimbine | 1994 |
Involvement of inhibitory dopamine-2 receptors in resting bradycardia in exercise-conditioned rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Bromocriptine; Clonidine; Female; Heart Rate; Metoclopramide; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Yohimbine | 1993 |
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.
Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Catecholamines; Clonidine; Female; Glucagon; Heart Rate; Humans; Immunohistochemistry; Male; Metoclopramide; Pheochromocytoma; Tomography, X-Ray Computed; Tyramine | 1993 |
Comparison of the effects of clonidine, loperamide and metoclopramide in two models of gastric emptying in the rat.
Topics: Acetaminophen; Animals; Clonidine; Gastric Emptying; Gastric Mucosa; Intestine, Small; Loperamide; Male; Metoclopramide; Phenolsulfonphthalein; Rats; Rats, Wistar | 2015 |